Effect of Botulinum Toxin A on the Autonomic Nervous System of the Rat Lower Urinary Tract
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (5) , 1896-1900
- https://doi.org/10.1097/01.ju.0000049202.56189.54
Abstract
The magnitude and duration of the effects of botulinum toxin A on acetylcholine (ACh) and norepinephrine release from the bladder and urethra of rats were measured using a radiochemical method. Saline (sham treatment) or botulinum toxin A was injected into the bladder (50 μl.) or urethra (30 μl.) in separate groups of animals. The release of 3H-norepinephrine or 14C-choline was measured at 2 time points after injection (5 or 30 days). The fractional release of ACh in botulinum toxin A treated animals was significantly inhibited at higher frequencies of electrical field stimulation (20 Hz.) but not at lower frequencies (2 Hz.) 5 days after injection. However, ACh release recovered to sham injected values 30 days after toxin injection. No significant differences in the fractional release of norepinephrine from sham injected or botulinum toxin A bladders were observed. In contrast, norepinephrine release from the urethra was inhibited by botulinum toxin A for at least 30 days after injection. Similar to its effect on transmitter release in the bladder, botulinum toxin A inhibited norepinephrine release in the urethra at high (20 Hz.) but not at low (4 Hz.) electrical stimulation frequencies. These data indicate that the clinical effects of botulinum toxin A on the lower urinary tract may vary depending on the site of injection and level of nerve activity.Keywords
This publication has 21 references indexed in Scilit:
- BOTULINUM-A TOXIN FOR TREATING DETRUSOR HYPERREFLEXIA IN SPINAL CORD INJURED PATIENTS: A NEW ALTERNATIVE TO ANTICHOLINERGIC DRUGS? PRELIMINARY RESULTSJournal of Urology, 2000
- Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminalsNeuroscience, 1999
- Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminalsProceedings of the National Academy of Sciences, 1999
- Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord diseaseSpinal Cord, 1998
- M1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C.The Journal of Physiology, 1996
- Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: A Prospective Study in 24 Spinal Cord Injury PatientsJournal of Urology, 1996
- Botulinum toxin type A inhibits Ca2+-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminalsNeuroscience Letters, 1995
- Botulinum toxin A for spasticity, muscle spasms, and rigidityNeurology, 1995
- Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury PatientsJournal of Urology, 1988